Circulating miRNAs have been proposed as the effective diagnostic biomarkers for muscular fibrosis-associated diseases. However, circulating biomarkers for early diagnosis of contracture muscles are limited in gluteal muscle contracture (GMC) patients. Here we sought to explore the abnormally expressed miRNAs in plasma and contraction bands of GMC patients. The results showed miR-29a-3p expression in plasma and contraction bands tissue was significantly reduced in GMC patients compared with normal control. Cell viability and levels of proliferation-associated protein cyclin D1 and cyclin-dependent-kinase 2 (CDK2) were powerfully inhibited by miR-29a mimics and enhanced by miR-29a inhibitor compared with negative control. Furthermore, miR-29a mimics effectively impeded, while miR-29a inhibitor enhanced the expression of collagen I and collagen III, followed by the secretion of transforming growth factor beta1 (TGF-beta1), TGF-beta3 and connective tissue growth factor (CTGF) in primary human contraction bands (CB) fibroblasts. The miR-29a-3p negatively regulated the expression of TGF-beta1 through binding to the 3´ UTR region of SERPINH1 (encoding heat shock protein HSP47), but had no effect on Smad2 activity. The miR-29a-3p was inversely correlated with HSP47 in contraction bands tissue from GMC patients. Collectively, miR-29a was notably depressed and regulated cell viability and fibrosis by directly targeting HSP47 in GMC, which suggest that circulating miR-29a might be a potential biomarker for early diagnosis and provides a novel therapeutic target for GMC.

Department of Sports Medicine Peking University Shenzhen Hospital Shenzhen China

Zobrazit více v PubMed

AGGARWAL A, SINGH S, SINGH M, CHAUHAN R. Idiopathic bilateral gluteus maximus contracture: a case report and review of literature. Acta Orthop Belg. 2005;71:493–495. PubMed

Al BAYATI MA, KRAIDY BK. Gluteal muscle fibrosis with abduction contracture of the hip. Int Orthop. 2016;40:447–451. doi: 10.1007/s00264-015-2836-1. PubMed DOI

ALI SO, DARWISH HA, ISMAIL NA. Modulatory effects of curcumin, silybin-phytosome and alpha-R-lipoic acid against thioacetamide-induced liver cirrhosis in rats. Chem Biol Interact. 2014;216:26–33. doi: 10.1016/j.cbi.2014.03.009. PubMed DOI

AMIN ND, BAI G, KLUG JR, BONANOMI D, PANKRATZ MT, GIFFORD WD, HINCKLEY CA, STERNFELD MJ, DRISCOLL SP, DOMINGUEZ B, LEE KF, JIN X, PFAFF SL. Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure. Science. 2015;350:1525–1529. doi: 10.1126/science.aad2509. PubMed DOI PMC

ARDITE E, PERDIGUERO E, VIDAL B, GUTARRA S, SERRANO AL, MUÑOZ-CÁNOVES P. PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J Cell Biol. 2012;196:163–175. doi: 10.1083/jcb.201105013. PubMed DOI PMC

BOWEN T, JENKINS RH, FRASER DJ. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J Pathol. 2013;229:274–285. doi: 10.1002/path.4119. PubMed DOI

CACCHIARELLI D, LEGNINI I, MARTONE J, CAZZELLA V, D’AMICO A, BERTINI E, BOZZONI I. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med. 2011;3:258–265. doi: 10.1002/emmm.201100133. PubMed DOI PMC

CHUANG TD, KHORRAM O. Tranilast inhibits genes functionally involved in cell proliferation, fibrosis, and epigenetic regulation and epigenetically induces miR-29c expression in leiomyoma cells. Reprod Sci. 2017;24:1253–1263. doi: 10.1177/1933719116682878. PubMed DOI

CUSHING L, KUANG PP, QIAN J, SHAO F, WU J, LITTLE F, THANNICKAL VJ, CARDOSO WV, LÜ J. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011;45:287–294. doi: 10.1165/rcmb.2010-0323oc. PubMed DOI PMC

EISENBERG I, ERAN A, NISHINO I, MOGGIO M, LAMPERTI C, AMATO AA, LIDOV HG, KANG PB, NORTH KN, MITRANI-ROSENBAUM S, FLANIGAN KM, NEELY LA, WHITNEY D, BEGGS AH, KOHANE IS, KUNKEL LM. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A. 2007;104:17016–17021. doi: 10.1073/pnas.0708115104. PubMed DOI PMC

FRIEDMAN RC, FARH KK, BURGE CB, BARTEL DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105. doi: 10.1101/gr.082701.108. PubMed DOI PMC

GRECO S, De SIMONE M, COLUSSI C, ZACCAGNINI G, FASANARO P, PESCATORI M, CARDANI R, PERBELLINI R, ISAIA E, SALE P, MEOLA G, CAPOGROSSI MC, GAETANO C, MARTELLI F. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009;23:3335–3346. doi: 10.1096/fj.08-128579. PubMed DOI

HELLER KN, MENDELL JT, MENDELL JR, RODINO-KLAPAC LR. MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin. JCI Insight. 2017;2:e93309. doi: 10.1172/jci.insight.93309. PubMed DOI PMC

HESSE E, TAIPALEENMÄKI H. MicroRNAs in bone metastasis. Curr Osteoporos Rep. 2019;17:122–128. doi: 10.1007/s11914-019-00510-4. PubMed DOI

HONG S, PARK K, KIM JH, HAN SH, LEE JB, SEONG GJ. Role of heat shock protein 47 in transdifferentiation of human tenon’s fibroblasts to myofibroblasts. BMC Ophthalmol. 2012;12:49. doi: 10.1186/1471-2415-12-49. PubMed DOI PMC

HU J, KONG M, YE Y, HONG S, CHENG L, JIANG L. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy. J Neurochem. 2014;129:877–883. doi: 10.1111/jnc.12662. PubMed DOI

INOUE K, NAITO Y, TAKAGI T, HAYASHI N, HIRAI Y, MIZUSHIMA K, HORIE R, FUKUMOTO K, YAMADA S, HARUSATO A, HIRATA I, OMATSU T, YOSHIDA N, UCHIYAMA K, ISHIKAWA T, HANDA O, KONISHI H, WAKABAYASHI N, YAGI N, ICHIKAWA H, KOKURA S, YOSHIKAWA T. Daikenchuto, a Kampo medicine, regulates intestinal fibrosis associated with decreasing expression of heat shock protein 47 and collagen content in a rat colitis model. Biol Pharm Bull. 2011;34:1659–1665. doi: 10.1248/bpb.34.1659. PubMed DOI

KAMIKAWAJI K, SEKI N, WATANABE M, MATAKI H, KUMAMOTO T, TAKAGI K, MIZUNO K, INOUE H. Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis. J Hum Genet. 2016;61:985–993. doi: 10.1038/jhg.2016.99. PubMed DOI

KARSDAL MA, NIELSEN SH, LEEMING DJ, LANGHOLM LL, NIELSEN MJ, MANON-JENSEN T, SIEBUHR A, GUDMANN NS, RONNOW S, SAND JM, DANIELS SJ, MORTENSEN JH, SCHUPPAN D. The good and the bad collagens of fibrosis - their role in signaling and organ function. Adv Drug Deliv Rev. 2017;121:43–56. doi: 10.1016/j.addr.2017.07.014. PubMed DOI

LEES T, NASSIF N, SIMPSON A, SHAD-KANEEZ F, MARTINIELLO-WILKS R, LIN Y, JONES A, QU X, LAL S. Recent advances in molecular biomarkers for diabetes mellitus: a systematic review. Biomarkers. 2017;22:604–613. doi: 10.1080/1354750x.2017.1279216. PubMed DOI

LI J, DU S, SHENG X, LIU J, CEN B, HUANG F, HE Y. MicroRNA-29b inhibits endometrial fibrosis by regulating the Sp1-TGF-beta1/Smad-CTGF axis in a rat model. Reprod Sci. 2016;23:386–394. doi: 10.1177/1933719115602768. PubMed DOI

LIU GH, CAO FQ, YANG SH, ZHU JF. Factors influencing the treatment of severe gluteal muscle contracture in children. J Pediatr Orthop B. 2011;20:67–69. doi: 10.1097/BPB.0b013e328341bcb2. PubMed DOI

LIU YJ, WANG Y, XUE J, LUI PP, CHAN KM. Arthroscopic gluteal muscle contracture release with radiofrequency energy. Clin Orthop Relat Res. 2009;467:799–804. doi: 10.1007/s11999-008-0595-7. PubMed DOI PMC

LLANO-DIEZ M, ORTEZ CI, GAY JA, ALVAREZ-CABADO L, JOU C, MEDINA J, NASCIMENTO A, JIMENEZ-MALLEBRERA C. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy. Neuromuscul Disord. 2017;27:15–23. doi: 10.1016/j.nmd.2016.11.003. PubMed DOI

MATSUZAKA Y, KISHI S, AOKI Y, KOMAKI H, OYA Y, TAKEDA S, HASHIDO K. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy. Environ Health Prev Med. 2014;19:452–458. doi: 10.1007/s12199-014-0405-7. PubMed DOI PMC

MENG XM, NIKOLIC-PATERSON DJ, LAN HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–338. doi: 10.1038/nrneph.2016.48. PubMed DOI

MIZUNO H, NAKAMURA A, AOKI Y, ITO N, KISHI S, YAMAMOTO K, SEKIGUCHI M, TAKEDA S, HASHIDO K. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One. 2011;6:e18388. doi: 10.1371/journal.pone.0018388. PubMed DOI PMC

MOREIRA SOARES OLIVEIRA B, DURBEEJ M, HOLMBERG J. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD. PLoS One. 2017;12:e0181950. doi: 10.1371/journal.pone.0181950. PubMed DOI PMC

MORIN S, De la PORTE S, FISZMAN M, KOENIG J. Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitro. Differentiation. 1995;59:145–154. doi: 10.1046/j.1432-0436.1995.5930145.x. PubMed DOI

OHLENDIECK K, SWANDULLA D. Molecular pathogenesis of Duchenne muscular dystrophy-related fibrosis. (In German) Pathologe. 2017;38:21–29. doi: 10.1007/s00292-017-0265-1. PubMed DOI

OLEAS-SANTILLÁN G, BOWEN JR. Anterior hip dislocation from post-injection gluteal muscular fibrosis: case report. JBJS Case Connect. 2019 doi: 10.2106/jbjs.cc.18.00250. PubMed DOI

RAI S, JIN SY, MENG CQ, CHAUDHARY N, TAMANG N, WANG XH, LIU XZ, WANG H, YANG S. Arthroscopic release using F and C method versus conventional open release method in the treatment of gluteal muscle contracture: a comparative study. BMC Musculoskelet Disord. 2017;18:113. doi: 10.1186/s12891-017-1484-6. PubMed DOI PMC

RAI S, MENG C, WANG X, CHAUDHARY N, JIN S, YANG S, WANG H. Gluteal muscle contracture: diagnosis and management options. SICOT J. 2017;3:1. doi: 10.1051/sicotj/2016036. PubMed DOI PMC

ROBERTS TC, BLOMBERG KE, McCLOREY G, El ANDALOUSSI S, GODFREY C, BETTS C, COURSINDEL T, GAIT MJ, SMITH CIE, WOOD MJA. Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther Nucleic Acids. 2012;1:e39. doi: 10.1038/mtna.2012.26. PubMed DOI PMC

SCULLY WF, WHITE KK, SONG KM, MOSCA VS. Injection-induced gluteus muscle contractures: diagnosis with the “reverse ober test” and surgical management. J Pediatr Orthoped. 2015;35:192–198. doi: 10.1097/bpo.0000000000000238. PubMed DOI

TAO R, FAN XX, YU HJ, AI G, ZHANG HY, KONG HY, SONG QQ, HUANG Y, HUANG JQ, NING Q. MicroRNA-29b-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL1A1 and COL3A1. J Cell Biochem. 2018;119:3199–3209. doi: 10.1002/jcb.26475. PubMed DOI

XIAO HB, LIU RH, LING GH, XIAO L, XIA YC, LIU FY, LI J, LIU YH, CHEN QK, LV JL, ZHAN M, YANG SK, KANWAR YS, SUN L. HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-beta1 through ERK1/2 and JNK MAPK pathways. Am J Physiol Renal Physiol. 2012;303:F757–F765. doi: 10.1152/ajprenal.00470.2011. PubMed DOI PMC

XU J, GENG X, MUHAMMAD H, WANG X, HUANG JZ, ZHANG C, MA X. Comparison of the incisions for the open surgical treatment of gluteal muscle contracture. J Pediatr Orthop B. 2014;23:435–440. doi: 10.1097/bpb.0000000000000067. PubMed DOI

YAMAKAWA T, OHIGASHI H, HASHIMOTO D, HAYASE E, TAKAHASHI S, MIYAZAKI M, MINOMI K, ONOZAWA M, NIITSU Y, TESHIMA T. Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease. Blood. 2018;131:1476–1485. doi: 10.1182/blood-2017-04-779934. PubMed DOI

YANG F, CHEN Q, HE S, YANG M, MAGUIRE EM, AN W, AFZAL TA, LUONG LA, ZHANG L, XIAO Q. miR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation. Circulation. 2018;137:1824–1841. doi: 10.1161/circulationaha.117.027799. PubMed DOI PMC

YANG J, ZHENG J, WU L, SHI M, ZHANG H, WANG X, XIA N, WANG D, LIU X, YAO L, LI Y, DOU K. NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-beta1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS One. 2011;6:e27710. doi: 10.1371/journal.pone.0027710. PubMed DOI PMC

ZANOTTI S, GIBERTINI S, BLASEVICH F, BRAGATO C, RUGGIERI A, SAREDI S, FABBRI M, BERNASCONI P, MAGGI L, MANTEGAZZA R, MORA M. Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis. Matrix Biol. 2018;74:77–100. doi: 10.1101/267963. PubMed DOI

ZANOTTI S, GIBERTINI S, CURCIO M, SAVADORI P, PASANISI B, MORANDI L, CORNELIO F, MANTEGAZZA R, MORA M. Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta. 18522015:1451–1464. doi: 10.1016/j.bbadis.2015.04.013. PubMed DOI

ZHANG X, JIANG X, HE F, LIANG Z, YOU T, JIN D, ZHANG W. Arthroscopic revision release of gluteal muscle contracture after failed primary open surgery. Int Orthop. 2017;41:1521–1526. doi: 10.1007/s00264-016-3354-5. PubMed DOI

ZHANG X, MA Y, YOU T, TIAN X, ZHANG H, ZHU Q, ZHANG W. Roles of TGF-beta/Smad signaling pathway in pathogenesis and development of gluteal muscle contracture. Connect Tissue Res. 2015;56:9–17. doi: 10.3109/03008207.2014.964400. PubMed DOI PMC

ZHANG Y, GHAZWANI M, LI J, SUN M, STOLZ DB, HE F, FAN J, XIE W, LI S. MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase. Biochem Biophys Res Commun. 2014;446:940–944. doi: 10.1016/j.bbrc.2014.03.037. PubMed DOI PMC

ZHAO CG, HE XJ, LU B, LI HP, KANG AJ. Increased expression of collagens, transforming growth factor-beta1, and -beta3 in gluteal muscle contracture. BMC Musculoskelet Disord. 2010;11:15. doi: 10.1186/1471-2474-11-15. PubMed DOI PMC

ZHAO CG, HE XJ, LU B, LI HP, WANG D, ZHU ZZ. Classification of gluteal muscle contracture in children and outcome of different treatments. BMC Musculoskelet Disord. 2009;10:34. doi: 10.1186/1471-2474-10-34. PubMed DOI PMC

ZHAO Y, SONG Y, YAO L, SONG G, TENG C. Circulating microRNAs: Promising biomarkers involved in several cancers and other diseases. DNA Cell Biol. 2017;36:77–94. doi: 10.1089/dna.2016.3426. PubMed DOI

miR-491-5p inhibits Emilin 1 to promote fibroblasts proliferation and fibrosis in gluteal muscle contracture via TGF-Beta1/Smad2 pathway